Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2006
12/20/2006EP1732576A1 Method for the photostabilisation of phycobiliproteins in an aqueous extract, compositions containing stabilised phycobiliproteins and use of stabilised phycobiliproteins
12/20/2006EP1732568A1 USES OF ERbeta MODULATORS
12/20/2006EP1732382A2 Sfec, a sperm flagellar energy carrier protein
12/20/2006EP1658309B1 Peptide protein translation inhibitor and the use thereof for protein translation control
12/20/2006EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors
12/20/2006EP1427440B1 Use of plasminogen for promoting healing of tympanic membrane perforation
12/20/2006EP1357935B1 Reducing side effects of chemotherapy in cancer patients
12/20/2006EP1353696B1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
12/20/2006EP1317537B1 G-csf analog compositions and methods
12/20/2006EP1311279B1 Treatment of hepatitis c with thymosin, interferon and ribavirin
12/20/2006EP1276472B1 Formulations for use in inhaler devices
12/20/2006EP1194164B1 Prion protein peptides and uses thereof
12/20/2006EP1146891B1 Therapy of restenosis and atherosclerosis with a soluble vegf receptor and angiopoeitin-1
12/20/2006EP1027027B1 Use of amylin, adrenomedullin and analogues thereof for treating cartilage defects
12/20/2006EP0972032B1 Peptides for the treatment of systemic lupus erythematosus
12/20/2006EP0942983B1 Streptococcus pneumoniae antigens and vaccines
12/20/2006CN1882704A A method for detecting nipah virus and method for providing immunoprotection against henipaviruses
12/20/2006CN1882357A Therapeutic use of factor XI
12/20/2006CN1882356A Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
12/20/2006CN1882355A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
12/20/2006CN1882348A Carbohydrate composition and its use for the preparation of a medicament for treating or preventing pulmonary inflammation or acute respiration distress syndrome
12/20/2006CN1882339A Amelioration of macular degeneration and other ophthalmic diseases
12/20/2006CN1882335A Combination therapy for HCV infection
12/20/2006CN1882325A Novel use of peptide compounds for treating central neuropathic pain
12/20/2006CN1880457A Ad6重组核酸 Ad6 recombinant nucleic acid
12/20/2006CN1880452A Human SEMA 4C gene capable of inhibiting myoblast multiplication and promoting differentiation to myotube
12/20/2006CN1880451A Method for preparing recombinant aprotinin
12/20/2006CN1880336A Cancer-targeted super antigen fusion protein and its production method
12/20/2006CN1879890A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/20/2006CN1879886A Sodium acetylide/ soybean separation protein commixed gel granule preparation method
12/20/2006CN1879884A Synergistic therapeutic compositions and methods
12/20/2006CN1879879A Medicinal injection for treating chronic pelvic inflammatory disease
12/20/2006CN1879878A Medicine for preventing and treating bee toxicosis from picking camellia and method
12/20/2006CN1879877A Tumour-specific animal proteins
12/20/2006CN1879876A Neurotrophic factor slow release microsphere and its preparation method
12/20/2006CN1879875A Preparations stabilized over long time
12/20/2006CN1879874A Glutathion complex pharmaceutical composition
12/20/2006CN1879610A Method for preparing oral administered sustained-release peptide micro capsule
12/20/2006CN1879608A Bioadhesive progressive hydration tablets
12/20/2006CN1291019C Novel natural antibacterial peptide HKABF and its preparation and application
12/20/2006CN1290907C A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
12/20/2006CN1290862C Spleen polypeptide extract, its preparing process and use
12/20/2006CN1290861C New type human bone marrow stroma cell source 1 type phosphatase inhibition factor, its coded sequence and use
12/20/2006CN1290858C Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
12/20/2006CN1290586C A haemostatic kit, a method of preparing a haemostatic agent
12/20/2006CN1290578C Polyglycol-interferon water solution
12/20/2006CN1290577C Application of interleukin-1 in medicine preparation process for treating glaucoma
12/20/2006CN1290576C Use of thymic hormone beta 15 in preparation of substances for promoting wound healing and generation of blood
12/20/2006CN1290575C Method for preparing technical product of lowering sugar of balsam pear containing active protein
12/20/2006CN1290574C Injection of donkey hide gelatin and its preparation
12/20/2006CN1290500C Retroviral protease inhibitor combinations
12/20/2006CN1290444C Intestinal absorbing fully nutrient emulsion for phymatostio patient and method for preparation same
12/20/2006CN1290443C Cellulosefree intestinal absorbing nutrient emulsion and its preparing method
12/20/2006CA2549086A1 Chimeric polypeptides and their therapeutic applications against a flaviviridae infection
12/19/2006USRE39433 Therapeutic agents as cytokine antagonists and agonists
12/19/2006US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery
12/19/2006US7151172 virion infectivity factor (vif) proteins; use in vaccine against the HIV-1 virus
12/19/2006US7151160 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2006US7151103 A serotonin receptor antagonists for therapeutic treatment
12/19/2006US7151088 Neuroprotective dietary supplement
12/19/2006US7151087 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
12/19/2006US7151086 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
12/19/2006US7151085 Therapeutic methods using cyclosporine components
12/19/2006US7151084 Compound and method of treating neurogenic conditions using non-steroidal anti-inflammatory drug complexes
12/19/2006US7151083 a synergistic mixture of Leutenizing Hormone or Human chorionic gonadotrophin and Follicle stimulating hormone to promote folliculogenesis in anovulatory women; improved fertility
12/19/2006US7151082 Administering an effective amount of an antagonist or inhibitor of high mobility group 1 protein (HMG1) for therapy of condition characterized by activation of the inflammatory cytokine cascade
12/19/2006US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/19/2006US7150976 Regulation of human serine-threonine protein kinase
12/19/2006US7150968 Bridging INtegrator-2 (Bin2) nucleic acid molecules and proteins and uses therefor
12/19/2006US7150966 Determining whether fluorescently labeled compound is phosphorylated via monitoring/measuring shift in polarized fluorescence
12/19/2006US7150883 Liposome suspension forms spontaneously upon adding a diacylglycerol-PEG lipid to an aqueous solution when the lipid has appropriate packing parameters and the adding occurs above the melting temperature of the lipid
12/19/2006US7150871 Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
12/19/2006US7150870 Treatment of tumors with superoxide dismutase for prevention by applying to tumors
12/19/2006US7150869 Gene therapy; cytokine complex; anticancer agent
12/19/2006US7150766 Method of particle formation
12/19/2006CA2364610C Pharmaceutical solubilized in aerosol propellant
12/19/2006CA2251169C Quaternary cytofectins
12/19/2006CA2234957C Insoluble drug delivery
12/15/2006CA2510056A1 Treatment of injury in mammalian cells
12/14/2006WO2006133450A2 Anti-cd19 antibody therapy for the transplantation
12/14/2006WO2006133403A2 Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survival
12/14/2006WO2006133391A2 Improved treatment for anemia using a hif-alpha stabilising agent
12/14/2006WO2006133338A1 INHIBITORS OF THE α2β1/GPIa-IIa INTEGRIN
12/14/2006WO2006133276A2 Methods for dissolving cystine stones and reducing cystine in urine
12/14/2006WO2006133196A1 Modulation of cholesteryl ester transfer protein (cetp) activity
12/14/2006WO2006133160A2 Compositions and methods for lipo modeling
12/14/2006WO2006133147A2 Organic compounds
12/14/2006WO2006133144A2 Erythropoietin receptor peptide formulations and uses
12/14/2006WO2006133089A2 Improved human interferon molecules and their uses
12/14/2006WO2006133088A2 Improved human interferon molecules and their uses
12/14/2006WO2006132867A1 Topical oligopeptide delivery system
12/14/2006WO2006132701A2 Methods and kits for regulation of microtubule assembly and dendrite growth and branching
12/14/2006WO2006132665A2 Biocides
12/14/2006WO2006132607A1 Mutant allergen(s)
12/14/2006WO2006132530A2 Methods and means for use in diagnostics and treatment of diabetes
12/14/2006WO2006132445A2 A pharmaceutical composition for treating and diagnosing a disorder associated with peroxisomal biogenesis and function
12/14/2006WO2006132406A1 Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea
12/14/2006WO2006132293A1 Food composition having immunosuppressive effect by coating antigen structure of allergenic protein by polysaccharide modification
12/14/2006WO2006132273A1 Composition comprising peptide having suppressive effect on food intake
12/14/2006WO2006132261A1 Therapeutic agent and/or prophylactic agent for neurogenic pain